Pedestrians walk by the Pfizer corporate headquarters in New York City (2020). On Monday the company said it was discontinuing development of a weight-loss drug in pill form. File Photo by John ...

Pfizer announced on Monday that it is halting development of its oral weight-loss pill after one patient experienced liver issues. The company said it halted development of danuglipron, an oral drug ...

AXIS Capital Holdings Limited (" AXIS Capital" or the "Company") (NYSE: AXS) today announced the publication of the Company's 2021 Loss Development Triangles. A copy of this document is available in ...

April 14 (UPI) --Pfizer on Monday announced it is halting development of a daily weight loss pill after one patient experienced a liver injury and previous problems with other pill versions. The ...